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Purpose.  To manufacture, and characterise, prednisolone-loaded Eudragit L100 microparticles using three different methods.  
Methods.  Extrusion-spheronisation:  Prednisolone, microcrystalline cellulose, lactose and H20 were wet massed and forced 
through a 0.5mm die, and the extrudate spheronised.  The resultant pellets were dried and  film-coated with a Eudragit L100 
aqueous dispersion.  Spray-drying:  Eudragit L100 (2.5-15%w/w) and prednisolone were dissolved in ethanol and spray-dried 
(inlet 60oC, outlet 40oC).  Emulsification/solvent evaporation:  Prednisolone and Eudragit L100 were dissolved in ethanol, 
and emulsified into liquid paraffin/surfactant under propeller stirring.  Following solvent evaporation, particles were collected 
by filtration.  All microparticles were characterised by SEM, and the pH-responsive release of prednisolone evaluated using 
USP II dissolution apparatus.  Results.  >85% of core pellets produced by extrusion-spheronisation were >500µm in 
diameter.  Coating of 500-710µm pellets was problematic, however pellets were coated to a 4-27% weight gain.  Spray-dried 
microparticles exhibited a collapsed morphology and were of size <30µm, increasing with Eudragit concentration, with the 
presence of some stringy aggregates.  Production yields were <10%, common to spray-drying.  After optimisation of process 
parameters, emulsification/solvent evaporation produced non-aggregated microparticles of size <50um, with a high degree of 
monodispersity.  During dissolution of Eudragit L100-coated pellets, a high polymer weight gain was required to keep 
prednisolone release <10% in acid, and drug release was therefore delayed at pH 6.8.  Wettability of the spray-dried particles 
was poor, due to collapsed and irregular morphology, and drug release after 2 hours in acid exceeded 10%.  Microparticles 
produced by emulsification/solvent evaporation dispersed well, and despite their small size, provided excellent control of 
drug release at acidic pH, whilst releasing 100% of prednisolone within 5 minutes at intestinal pH.  Conclusions.  The 
emulsification/solvent evaporation method is superior to other approaches, in terms of particle size, morphology and control 
of drug release, for the production of Eudragit L100 microparticles. 
 
